Maxbac 250mg IV/IM Injecti

Maxbac 250mg IV/IM Injecti, classified under the anti-infectives therapeutic class, is a formulation of Ceftazidime, an antibiotic belonging to the cephalosporin class. Each vial of Maxbac 250mg IV/IM Injecti 10 contains 250 mg of Ceftazidime USP (as Pentahydrate), accompanied by Sodium Carbonate as a buffer. The medication is provided in a form that requires reconstitution, and for this purpose, each package includes an ampoule containing 5 ml of water for injection. Additionally, Maxbac 250mg IV/IM Injecti is supplied with a sterile disposable syringe, an alcohol prep pad, and a strip bandage, facilitating safe and sterile administration.

Ceftazidime, the active ingredient in Maxbac 250mg IV/IM Injecti, is indicated for the treatment of a variety of bacterial infections. This antibiotic is particularly effective against Gram-negative bacteria and is used in the treatment of severe or life-threatening infections like pneumonia, urinary tract infections, skin infections, intra-abdominal infections, and infections in immunocompromised patients. Ceftazidime is also commonly used in hospital settings for managing infections in patients with limited treatment options due to antibiotic resistance.

The dosage of Maxbac 250mg IV/IM Injecti (Ceftazidime) varies depending on the type, severity, and site of infection, as well as the patient's age, weight, and renal function. The reconstituted solution is administered intravenously or intramuscularly. For adult patients, the typical dose ranges but should always be determined by a healthcare professional based on specific patient needs.

The administration of Maxbac 250mg IV/IM Injecti involves reconstituting the Ceftazidime powder in the vial with the provided sterile water for injection. The solution should be prepared using aseptic techniques, utilizing the alcohol prep pad for cleaning and the sterile syringe for administration. After reconstitution, the solution must be used within a specified period to maintain its efficacy and reduce the risk of contamination. Patients and caregivers should be instructed in proper preparation and administration techniques, and the use of the strip bandage for post-injection care.

It is essential to complete the full course of therapy as prescribed, even if symptoms improve, to ensure the effective treatment of the infection and reduce the risk of developing antibiotic resistance. Any adjustments in dosage or treatment regimen should be made under the guidance of a healthcare provider.